Document:

ex4-4.htm

Exhibit 4.4

 

EXHIBIT A

 

NOTICE OF EXERCISE – WARRANT

 

 

TO:     BIOLARGO, INC.

 

(1) The undersigned hereby elects to purchase _____________ common shares of the Company (maximum allowed: [________]) pursuant to the terms of the attached Warrant, and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.

 

(2) Unless said Warrant Shares will be delivered electronically via DWAC, please issue the Warrant Shares in the name of the undersigned or in such other name as is specified below in “book entry” form at the Company’s transfer agent. 

 

If the Warrant Shares will be delivered electronically via DWAC, please issue them to the following account:

 

Name of DTC Participant (broker-dealer at which the account of Holder to be

credited with the Warrant Shares is maintained): _______________________________________

 

DTC Participant Number: _______________________________________

 

Name of Account at DTC Participant to be credited with the Shares: _______________________

______________________________________________________________________________

 

Account Number at DTC Participant to be credited with the Shares: _______________________________

 

 

_______________________________________

[SIGNATURE OF HOLDER]

 

Name of Investing Entity: ________________________________________________________________________

 

Signature of Authorized Signatory of Investing Entity: _______________________________________

Name of Authorized Signatory: _________________________________________________________

Title of Authorized Signatory: __________________________________________________________

Date: ___________________________________________________

Address for delivery of shares (no PO boxes): ______________________________________________

____________________________________________

 

Social Security Number / Tax Identification Number: ________________________________________

 

 

 

 

 

EXHIBIT B

 

NOTICE OF TRANSFER –WARRANT

 

(To be signed only upon transfer of Warrant and subject to other conditions of this Warrant)

 

FOR VALUE RECEIVED, the undersigned hereby sells, assigns and transfers unto ____________________________________________ the right represented by the attached Warrant to purchase __________ shares of the Common Stock of BIOLARGO, INC., to which the attached Warrant relates, and appoints _____________________ as Attorney-in-fact to transfer such right on the books of BIOLARGO, INC., with full power of substitution in the premises.

 

The undersigned understands that any transfer of the attached Warrant is subject to full compliance with Federal and applicable state securities laws and other requirements, which requirements shall be determined and which issues shall be decided by BIOLARGO, INC., in its sole and absolute discretion, prior to consenting to and recognizing such transfer.

 

Dated:                            

 

 

	
 
	
 

	
 
	
(Signature must conform in all respects to the name of the Holder as specified on the face of the Warrant)

	
 
	
 

	
 
	
 

	
 
	
 

	
 
	
 

	 	
                                                (Address)

 

 

Signed in the presence of:This Consulting Agreement, dated
effective August, 2015 (this “Agreement”), is made and entered into by and between Rx Safes, Inc. (the “Company”)
and Faruk Okcetin (the “Consultant”).

 

ARTICLE
1 SCOPE OF WORK

 

1.1              
Services. The Company has engaged the Consultant to provide services in connection with the
Company’s sale and distribution of its flagship Rx DrugSAFE product as well as creating
opportunities for other products and solutions the Company may offer now or in the future, collectively referred to as the “Products”.
Consultant will introduce the Company to sales opportunities, strategic partners and such other services as the Company and Consultant
may deem appropriate (collectively, the “consulting services”).

1.2              
Time and Availability. Consultant shall have discretion in selecting the dates and times it
performs such consulting services throughout the month giving due regard to the needs of the Company’s
business.

1.3              
Confidentiality. In order for Consultant to perform the consulting services, it may be necessary
for the Company to provide Consultant with Confidential Information (as defined below) regarding the Company’s business and
products. The Company will rely heavily upon Consultant’s integrity and prudent judgment to use this information only in
the best interests of the Company.

1.4              
Standard of Conduct. In rendering consulting services under this Agreement, Consultant shall
conform to high professional standards of work and business ethics. Consultant shall not use time, materials, or equipment of the
Company without the prior written consent of the Company. In no event shall Consultant take any action or accept any assistance
or engage in any activity that would result in any university, governmental body,
research institute or other person, entity, or organization acquiring any rights of any nature in the results of work performed
by or for the Company.

1.5              
Outside Services. Consultant shall not use the service of any other person, entity, or organization
in the performance of Consultant’s duties without the prior written consent of an officer of the Company. Should the Company
consent to the use by Consultant of the services of any other person, entity, or organization, no information regarding the services
to be performed under this Agreement shall be disclosed to that person, entity, or organization until such person, entity, or organization
has executed an agreement to protect the confidentiality of the Company’s Confidential
Information (as defined in Article 5) and the Company’s absolute and complete ownership of all right, title, and interest
in the work performed under this Agreement.

1.6              
Reports. Consultant shall periodically provide the Company with written reports of his observations
and conclusions regarding the consulting services. Upon the termination of this Agreement, Consultant shall, upon the request of
Company, prepare a final report of Consultant’s activities.

 

ARTICLE
2 INDEPENDENT CONTRACTOR

 

2.1              
Independent Contractor. Consultant is an independent contractor and is not an
employee, partner, of, or in any other service relationship with, the Company. The manner in which Consultant’s services
are rendered shall be within Consultant’s sole control and discretion. Consultant is not authorized to speak for, represent,
or obligate the Company in any manner without the prior express written authorization from an officer of the
Company.

2.2              
Taxes. Consultant shall be responsible for all taxes arising from compensation and other amounts
paid under this Agreement, and shall be responsible for all payroll taxes and fringe benefits of Consultant’s employees.
Neither federal, nor state, nor local income tax, nor payroll tax of any kind, shall be withheld or paid by the Company on behalf
of Consultant or his employees. Consultant understands that he is responsible to pay, according to law, Consultant’s taxes
and Consultant shall, when requested by the Company, properly document to the Company
that any and all federal and state taxes have been paid.

2.3              
Benefits. Consultant and Consultant’s employees will not be eligible for, and shall
not

 

    	 	1	 

    	 

    

 

participate in, any employee pension,
health, welfare, or other fringe benefit plan of the Company. No workers' compensation insurance shall be obtained by Company covering
Consultant or Consultant’s employees.

 

ARTICLE
3

COMPENSATION
FOR CONSULTING SERVICES

 

3.1              
Retainer. Upon execution of this Agreement, the Company shall pay to Consultant an initial
retainer of 1,000,000, restricted shares of Rx Safes, Inc. common stock. This initial retainer
shall be paid regardless of the number of consulting hours provided by Consultant.

3.2                
Commission. For any sales of the Company’s products directly attributable to the efforts
of the Consultant, Consultant will be paid a commission of 10% of the net sales to the
Company for as long as any agreement is in effect between the Company and any Client directly
introduced to Company by Consultant, and for a tail period of 24 months after the last date of any agreement, whether terminated
or otherwise expired between Company and Client or 24 months after delivery of the product to the Client, whichever is later in
time. The Company may, at its sole discretion, pursue sales opportunities independent of Consultant, at the same target Client
Consultant is pursuing. Any attempt by the Company to target the same Client shall be immediately disclosed, in writing, to Consultant.
If the Company secures a sale at a target Client, independent of efforts made by Consultant, Consultant will not be entitled to
commission for such a sale.

 

ARTICLE
4

TERM AND TERMINATION

 

4.1              
Term. This Agreement shall be effective as of
August , 2015, and shall continue in
full force and effect for 12 consecutive months. The Company and Consultant may negotiate to extend the term of this Agreement
and the terms and conditions under which the relationship shall continue.

4.2              
Termination. The Company may terminate this Agreement for “Cause,” after giving
Consultant written notice of the reason. Cause means: (1) Consultant has breached the provisions of Article 5 or 7 of this Agreement
in any respect, or materially breached any other provision of this Agreement and the breach continues for 30 days following receipt
of a notice from the Company; (2) Consultant has committed fraud, misappropriation, or embezzlement in connection with the Company’
s business; (3) Consultant has been convicted of a felony; or (4) Consultant’s use of narcotics, liquor, or illicit drugs
has a detrimental effect on the performance of his or her employment responsibilities,
as determined by the Company. Termination of this Agreement has no effect on commissions earned or on future commissions generated
from Clients previously cultivated by Consultant. other than what is reflected in paragraph 3.2
above.

4.3              
Responsibility upon Termination. Any equipment provided by the Company to the Consultant in
connection with or furtherance of Consultant’s services under this Agreement,
including, but not limited to, computers, laptops, and personal management tools, shall, immediately upon the termination of this
Agreement, be returned to the Company.

4.4              
Survival. The provisions of Articles 3, 5, 6, 7, and 8 of this Agreement shall survive
the termination of this Agreement and remain in full force and effect thereafter.

 

ARTICLE
5 CONFIDENTIAL INFORMATION

 

5.1              
Obligation of Confidentiality. In performing consulting services under this Agreement, Consultant
may be exposed to and will be required to use certain “Confidential Information” (as hereinafter defined) of the Company.
Consultant agrees that Consultant will not and Consultant’s employees, agents,
or representatives will not use, directly or indirectly, such Confidential Information for the benefit of any person, entity, or
organization other than the Company, or disclose such Confidential Information without the written authorization of
the CEO of the Company, either during or after the term of this Agreement, for as long as such information retains the characteristics
of Confidential Information.

 

    	 	2	 

    	 

    

 

5.2              
Definition. “Confidential Information” means information not generally known and
proprietary to the Company, including, without limitation, information concerning any patents or trade secrets, confidential or
secret designs, processes, formulae, source codes, plans, devices or material, research and development, proprietary software,
analysis, techniques, materials, or designs (whether or not patented or patentable), directly or indirectly useful in any aspect
of the business of the Company, any vendor names, customer and supplier lists, databases, management systems and sales and marketing
plans of the Company, any confidential secret development or research work of the Company, or any other confidential information
or proprietary aspects of the business of the Company. All information which Consultant acquires
or becomes acquainted with during the period of this Agreement, whether developed by Consultant or by others, which Consultant
has a reasonable basis to believe to be Confidential Information, or which is treated by the Company as being Confidential Information,
shall be presumed to be Confidential Information.

5.3               Property
of the Company. Consultant agrees that all plans, manuals, and specific materials developed by the Consultant on behalf of
the Company in connection with services rendered under this Agreement, are and shall remain the exclusive property of the
Company. Promptly upon the expiration or termination of this Agreement, or upon the request of the Company, Consultant shall
return to the Company all documents and tangible items, including samples, provided to Consultant or created by Consultant
for use in connection with services to be rendered hereunder, including, without limitation, all Confidential Information,
together with all copies and abstracts thereof.

 

ARTICLE
6 RIGHTS AND DATA

 

All methods, documents, and tangible
items prepared for and submitted to the Company by Consultant in connection with the services rendered under this Agreement shall
belong exclusively to the Company and shall be deemed to be works made for hire (the “Deliverable Items”). To the extent
that any of the Deliverable Items may not, by operation of law, be works made for hire, Consultant hereby assigns to the Company
the ownership of copyright or mask work in the Deliverable Items, and the Company shall have the right to obtain and hold in its
own name any trademark, copyright, or mask work registration, and any other registrations and similar protection which may be available
in the Deliverable Items. Consultant agrees to give the Company or its designees all assistance reasonably required to perfect
such rights.

 

ARTICLE
7 CONFLICT OF INTEREST

 

Conflict of Interest. Consultant
covenants and agrees not to consult or provide any services in any manner or capacity to a direct competitor of the Company during
the duration of this Agreement, unless express written authorization to do so is given by the Company. A direct competitor of the
Company for purposes of this Agreement is defined as any individual, partnership, corporation, and/or other business entity that
engages in the business of developing products and/or solutions to address medical and drug security issues for us within the home
and/or healthcare facilities.

ARTICLE 8

RIGHT
TO INJUNCTIVE RELIEF

 

Consultant acknowledges that the
terms of Articles 5, 6, and 7 of this Agreement are reasonably necessary to protect the legitimate interests of the Company, are
reasonable in scope and duration, and are not unduly restrictive. Consultant further acknowledges that a breach of any of the terms
of Articles 5, 6, or 7 of this Agreement will render irreparable harm to the Company, and that a remedy at law for breach of the
Agreement is inadequate, and that the Company shall therefore be entitled to seek any and all equitable relief, including, but
not limited to, injunctive relief, and to any other remedy that may be available under any applicable law or agreement between
the parties. Consultant acknowledges that an award of damages to the Company does not preclude a court from ordering injunctive
relief. Both damages and injunctive relief shall be

 

    	 	3	 

    	 

    

 

proper modes of relief and are not
to be considered as alternative remedies.

 

ARTICLE
9 GENERAL PROVISIONS

 

9.1              
Construction of Terms. If any provision of this Agreement is held unenforceable by a
court of competent jurisdiction, that provision shall be severed and shall not affect the validity or enforceability of
the remaining provisions.

9.2              
Governing Law. This Agreement shall be governed by and construed in accordance with the internal
laws (and not the laws of conflicts) of the State of Nevada.

9.3              
Complete Agreement. This Agreement constitutes the complete agreement and sets
forth the entire understanding and agreement of the parties as to the subject matter of this Agreement and supersedes all
prior discussions and understandings in respect to the subject of this Agreement, whether written or
oral.

9.4              
Dispute Resolution. If there is any dispute or controversy between the parties arising out
of or relating to this Agreement, the parties agree that such dispute or controversy will be arbitrated in accordance with proceedings
under American Arbitration Association rules, and such arbitration will be the exclusive
dispute resolution method under this Agreement. The decision and award determined by such arbitration will be final and binding
upon both parties. All costs and expenses, including reasonable attorney’s fees and expert’s fees, of all parties incurred
in any dispute that is determined and/or settled by arbitration pursuant to this Agreement will be borne by the party determined
to be liable in respect of such dispute; provided, however, that if complete liability is not assessed against only one party,
the parties will share the total costs in proportion to their respective amounts of liability so determined. Except where clearly
prevented by the area in dispute, both parties agree to continue performing their respective obligations under this Agreement until
the dispute is resolved.

9.5              
Modification. No modification, termination, or attempted waiver of this Agreement, or any
provision thereof, shall be valid unless in writing signed by the party against whom the same is sought to be
enforced.

9.6              
Waiver of Breach. The waiver by a party of a breach of any provision of this Agreement by
the other party shall not operate or be construed as a waiver of any other or subsequent breach by the party in
breach.

9.7              
Successors and Assigns. This Agreement may not be assigned by either party without
the prior written consent of the other party; provided, however, that the Agreement shall be assignable by the Company without
Consultant’s consent in the event the Company is acquired by or merged into another corporation or business entity. The benefits
and obligations of this Agreement shall be binding upon and inure to the parties hereto, their successors and
assigns.

9.8              
No Conflict. Consultant warrants that Consultant has not previously assumed
any obligations inconsistent with those undertaken by Consultant under this Agreement.

 

IN WITNESS WHEREOF, this Agreement
is executed as of the date set forth above.

 

Rx
Safes, Inc.

 

By: /s/ Lorraine Yarde

Name: Lorraine Yarde

 

 

Frank Okcetin

 

By: /s/ Frank Okcetin

Name: Frank Okcetin

 

    	 	4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00261-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00261-of-00352.parquet"}]]